Completed PHASE2 INTERVENTIONAL 3-arm NCT01701505

Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects

A Phase 2, Single-Center, Open-Label, Randomized, Parallel-Groups, Dose-Ranging Study to Assess the Efficacy and Safety of Intranasally Administered Kovacaine Mist for Anesthetizing Maxillary Teeth in Pediatric Subjects

Sponsor: Rho, Inc.

Conditions Anesthesia

Interventions 120uL of Kovacaine Mist 200uL of Kovacaine Mist 400uL of Kovacaine Mist

Updated 9 times since 2017 Last updated: Jul 28, 2017 Started: Oct 31, 2012 Primary completion: Oct 31, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anesthesia, this trial is completed. The trial is conducted by Rho, Inc. and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Sep 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Sep 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rho, Inc.
St. Renatus, LLC
Triligent International

Data source: St. Renatus, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Collins, United States